trial · primary record
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR
B-cell Leukemia
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2029-06-30 |
| Primary endpoint | Safety of infusion |
| Registry ID | NCT04016129 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:29.996Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04016129
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.